ArticleClinical pharmacokinetics2016

Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I Studies.

Akshanth R Polepally et al.PubMed ↗Publisher ↗

No numbers read from the abstract.